Impact Factor
3.07
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.85
481 total citations
h5-index
26
h5 depth signal
Cited share
69.1%
183 of 265
Total citations
481
Citation footprint
Metric signal
2.80
External metric anchor
Self-citation
27.4%
132 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
724
United Kingdom
253
China
193
Germany
130
Switzerland
124
Citing Fields of Research
Mass Spectrometry
1,006
Clinical Laboratory Science
575
Separation Techniques
372
Pharmacology & Toxicology
323
Immunology
125
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,749
Articles tracked across the journal lifetime
Indexed publication set
265
183 cited publications
Last 12 months
152
12.7 publications/month
Open access share
23.7%
36 OA publications in the last year
Leading citing country
United States
724 citing publications
Leading citing field
Mass Spectrometry
1,006 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Apr. 2009-
v1n1, Apr. 2009-
Active Coverage
Research Focus & Classification
Indexed Subjects
Mass Spectrometry
Clinical Laboratory Science
Pharmacology & Toxicology
Separation Techniques
Immunology
Broad Categories
Chemistry Techniques, Analytical
Mass Spectrometry
Separation Techniques
Immunotherapy
Clinical Laboratory Science
Biosensors
MeSH Descriptors
Chemistry Techniques, Analytical
Pharmaceutical Preparations
Technology, Pharmaceutical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17576180.2026.2746943
Open DOI
Bioanalytical assays for clinical similarity assessment of biotherapeutics: evolving platforms and regulatory considerations
02
03
DOI 10.1080/17576180.2026.2744031
Open DOI
Optimization of hemolysis index thresholds for biochemical and immunoassays
04
DOI 10.1080/17576180.2026.2744071
Open DOI
Applications of enzyme activity assays in clinical development for rare disease therapeutics
05
06
DOI 10.1080/17576180.2026.2744036
Open DOI
Bedside analysis of volatile organic compounds in exhaled human breath as non-invasive diagnostic tool for colon diseases
07
DOI 10.1080/17576180.2026.2744032
Open DOI
Development and pre-qualification of a facile and ultra-sensitive LRRK2 LC/MS assay using high-affinity unmodified immobilization for immunocapture: meet bioanalytical challenges and search practical solutions
1. Globally, neurological disorders are a leading cause of disability [1]. Among these disorders, Parkinson’s disease (PD) has the fastest-growing prevalence rate [2,3]. PD is a progressive neurode...
08
DOI 10.1080/17576180.2026.2739128
Open DOI
Recent developments in microsampling for oligonucleotides and biologics bioanalysis
09
DOI 10.1080/17576180.2026.2739184
Open DOI
A review of microsampling techniques for the analysis of chemical threat agents in biological matrices
10
DOI 10.1080/17576180.2026.2740919
Open DOI
Glycosylation-based distinction of endogenous and recombinant complement factor H enables selective quantification in human plasma
1. Biologics are an emerging class of new modality drug molecules characterized by their close similarity to endogenous macromolecules. For certain therapeutic proteins – such as replacements for p...
Bibliographical & Catalog Notes
Latest issue consulted: Vol. 1, no. 8 (Nov. 2009).
Vol. 1 complete in nine issues.
Also issued online.